The sale process lasted a little over one year and its completion was marked in December 2021.
Real estate consulting firm JLL assisted GSK in the sale process.
The production of the plant in Cluj went to export alone, with Russia being the main market.
The construction of the Ferrosan factory was completed in 2015 and the space consists of a separate office building of 2,000 sqm, approximately 3,800 sqm of warehouses and almost 12,800 sqm of land.
GSK, one of the leading players in the global medical field, entered the Romanian market over 30 years ago. The factory in Cluj reached GSK’s portfolio in 2019, following an international joint venture formed with Pfizer.
GSK was assisted in all legal aspects of the transaction by lawyers from Bancila, Diaconu and Asociatii SPRL with a team made up of Roxana Dudau and Alexandra Siminiceanu. Hexagon was legally advised by law firm Popovici Nitu Stoica & Asociatii (PNSA).